Immunological and clinical effects of post-transplant G-CSF versus placebo in T-cell replete allogeneic blood transplant patients: results from a randomized double-blind study

Author： Joshi Ss   Bishop Mr   Lynch Jc   Tarantolo Sr   Abhyankar S   Bierman Pj   Vose Jm   Geller Rb   Mcguirk J   Foran J   Bociek Rg   Hadi A   Day Sd   Armitage Jo   Kessinger A   Pavletic Zs  

Publisher： Ashgate Publishing Ltd

ISSN： 1465-3249

Source： Cytotherapy, Vol.5, Iss.6, 2003-12, pp. : 542-552

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunological properties of mononuclear cells from blood stem cell harvests following mobilization with erythropoietin + G-CSF in cancer patients

By Joshi S.   Miller K.   Jackson J.D.   Warkentin P.   Kessinger A.  

Cytotherapy, Vol. 2, Iss. 1, 2000-01 ,pp. : 15-24

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A randomized controlled clinical trial to determine the optimum duration of G-CSF priming prior to BM stem cell harvesting

By Lowenthal Rm   Ragg Sj   Anderson J.   Nicholson L.   Harrup Ra   Tuck D.  

Cytotherapy, Vol. 9, Iss. 2, 2007-01 ,pp. : 158-164

Ashgate Publishing Ltd

Access to resources Recommend Favorite

A combination of granulocyte-colony-stimulating factor (G-CSF) and plerixafor mobilizes more primitive peripheral blood progenitor cells than G-CSF alone: results of a European phase II study

By Fruehauf Stefan   Veldwijk Marlon Romano   Seeger Timon   Schubert Mario   Laufs Stephanie   Topaly Julian   Wuchter Patrick   Dillmann Falk   Eckstein Volker   Wenz Frederik   Goldschmidt Hartmut   Ho Anthony Dick   Calandra Gary  

Cytotherapy, Vol. 11, Iss. 8, 2009-11 ,pp. : 992-1001

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Allogeneic stem-cell transplantation for lymphoproliferative disorders using BEAM–CAMPATH (± fludarabine) conditioning combined with post-transplant donor-lymphocyte infusion

By Lush RJ   Haynes AP   Byrne Jl   Cull GM   Carter GI   Pagliuca A   Parker JE   Mufti G   Mahendra P   Craddock CF   Lui Yin JA   Garg M   Prentice HG   Potter MN   Russell NH  

Cytotherapy, Vol. 3, Iss. 3, 2001-05 ,pp. : 203-210

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Production of good manufacturing practice-grade cytotoxic T lymphocytes specific for Epstein–Barr virus, cytomegalovirus and adenovirus to prevent or treat viral infections post-allogeneic hematopoietic stem cell transplant

By Sili Uluhan   Leen Ann M.   Vera Juan F.   Gee Adrian P.   Huls Helen   Heslop Helen E.   Bollard Catherine M.   Rooney Cliona M.  

Cytotherapy, Vol. 14, Iss. 1, 2012-01 ,pp. : 7-11

Ashgate Publishing Ltd

Access to resources Recommend Favorite